NONSMALL CELL LUNG CANCER
Clinical trials for NONSMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can weaker lung cancer patients handle the same powerful treatment?
Disease control Recruiting nowThis study looks at whether people with advanced non-small cell lung cancer who are in poorer health (performance status 2) can benefit from the same first-line chemo/immunotherapy as those in better health. About 105 participants will be treated and followed to compare cancer pr…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 16, 2026 22:28 UTC
-
New hope for lung cancer: first human trial of DZD6008 begins
Disease control Recruiting nowThis early-stage study tests a new drug, DZD6008, in people with advanced non-small cell lung cancer that has a specific EGFR mutation. The main goals are to check the drug's safety and find the right dose. About 190 adults will take part, and researchers will also watch for any …
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Targeted radiation zaps Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis study tests a new drug that delivers radiation directly to cancer cells with a specific marker (GRPR). It is for adults with advanced cancers like prostate, breast, lung, or colon cancer that have come back or spread. The main goal is to find a safe dose and check for side e…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Orano Med LLC • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New program aims to ease emotional burden of advanced lung cancer
Symptom relief Recruiting nowThis study is testing a new supportive care program called POISE for people with advanced non-small cell lung cancer. The program includes four visits with a specially trained palliative care clinician to help patients cope with uncertainty and manage their cancer journey. Resear…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 16, 2026 22:27 UTC